Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00588094 Information provided by Memorial Sloan-Kettering Cancer Center

First Received: December 26, 2007 Last Updated: March 17, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Carboplatin
Ifosfamide
Rituximab

More general drug interventions related to this trial

Sponsors listed in this trial